PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008 2009
ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS
- Updated with FY09 procurement information
- SCMS will procure all rapid tests kits in FY09 because AXIOS, which was programmed to purchase kits in
COP08, no longer participates in the Pfizer initiative and did not procure any kits in FY08.
COMPLETE NARRATIVE
Background
Since May 2005, SCMS has been designated as the primary procurement agent for PEPFAR-funded
commodities in Cote d'Ivoire and the principal provider of technical assistance for the HIV/AIDS
commodities supply chain, especially for forecasting and management. As PEPFAR-supported HIV/AIDS
care and treatment program scales up, SCMS procures most drugs, lab supplies, and other commodities for
PEPFAR implementing partners. As of September 2008, SCMS is procuring ARVs for 39,000 patients, with
a target of 60,000 ART patients by September 2009. A critical component of SCMS support is strengthening
the data-management and leadership capacities of the Ministry of Health (MOH) to enable it to play its
national oversight role more effectively. SCMS will ensure that regular, detailed, and concrete commodities
data and analyses are available to inform all stakeholders and empower the MOH to make appropriate
evidence-based decisions.
During the past three years, SCMS has provided technical assistance to strengthen the institutional capacity
of the Public Health Pharmacy (PSP) and of at least 68 selected health districts and HIV/AIDS care and
treatment sites to improve the management of drugs and commodities. SCMS has provided ongoing
technical and management support to HIV/AIDS supply-chain coordination at the central and district levels.
This includes:
• Preparing detailed national HIV/AIDS commodities forecasts and supply plans and periodic supply plan
updates with MOH, UNITAID, Global Fund (GF), Clinton Foundation, and other key PEPFAR implementing
partner data;
• Improving the availability of reliable data for decision-making, needs projections, and stock management
systems;
• Assessing warehousing and distribution functions of the PSP and selected treatment sites;
• Building capacity and developing new standards of practice for commodities management at the PSP
warehouse;
• Establishing a system for tracking of ARVs and other HIV/AIDS commodities through the PSP to treatment
sites as well as strengthening commodities-management systems and practices at the district level through
the implementation of various tools, including SIMPLE-1 and SIMPLE-2 software as well as paper-based
ARV logistics management information systems (LMIS) tools aimed at ensuring continued availability of
commodities at service-delivery points;
• Building capacity of the national health system through technical assistance activities, systems
development, and programmatic support.
Following directives from the MOH, all incoming commodities are delivered to the PSP for storage and
subsequent distribution to service sites. Following MOH policy to coordinate procurement, and in an effort to
improve efficiency of donors, SCMS has followed an approach of integration and complementarity under
which more than one donor provides inputs to a given site. The government of Cote d'Ivoire also buys small
amounts of commodities with its own funds..
In addition to procuring most HIV/AIDS-related drugs and consumables for PEPFAR Cote d'Ivoire, SCMS
will use FY09 funds to continue strong technical and management assistance in support of the PSP's
leadership and coordination role in the national program. SCMS will be held accountable for specific
performance results and will adjust its operational plan, in consultation with the USG team, the National
HIV/AIDS Care and Treatment Program (PNPEC), and the PSP, as the situation in Cote d'Ivoire evolves.
SCMS will regularly update national HIV/AIDS commodities forecast and validate calculations based on
actual use patterns and will provide ongoing analysis of commodities consumption compared to patient
treatment data. This is critical to ensure rational commodities management and realistic scale-up planning.
SCMS will also advise the MOH and partners on current pharmaceutical market developments, USG-
approved products and suppliers, and manufacturing capacity as it affects supply to Cote d'Ivoire.
With FY09 funding, in coordination with the MOH, GF, other key donors and PEPFAR partners, SCMS will
focus on continuing systems-strengthening activities, including quantifications, stock management,
warehousing, and distribution processes at the central level, and will support the PSP to develop and
disseminate a sustainable decentralization plan, further improving in-country supply-chain processes at the
regional and district levels. With FY09 funding, SCMS will strengthen the LMIS=) by providing technical
assistance to assess and enhance existing systems and/or develop new tools to better inform traceability of
ARVs and other commodities used in the treatment of persons living with HIV and AIDS (PLWHA).
PMTCT
SCMS is the only procurement agent for PMTCT commodities for PEPFAR-funded sites. With FY08 funds,
SCMS is procuring consumables and rapid test kits for PMTCT for a target of 215,000 patients. SCMS and
PEPFAR implementing partners (EGPAF, ICAP, and ACONDA) coordinate closely with other donors
planning to support PMTCT services and commodities at non-PEPFAR-supported sites. As the Cote
d'Ivoire program expands, SCMS is playing a key role in providing technical assistance to coordinate
accurate and frequent commodities forecasts and improve real-time stock management activities at facility,
district, and central levels of the health system. The PEPFAR program also collaborate with reproductive-
health and family-planning activities of other donors to strengthen wraparound services at PMTCT sites,
improve quality of care and client satisfaction, and decrease drop-outs.
FY09 Activities
Procurement
Activity Narrative: With FY09 funds, SCMS will procure HIV rapid test kits and lab consumables for PEPFAR implementing
partners (EGPAF, ICAP, and ACONDA) based on a projected 240,000 pregnant women to be tested, at an
estimated cost of $6.26 per woman. These supplies are in addition to other testing materials to be procured
for non-PMTCT care and treatment services
ARV drugs for treatment-eligible women identified through the PMTCT program and post-exposure
prophylaxis (PEP) are included among PEPFAR ARV commodities elsewhere in the COP09. Other
commodities and support to be provided to HIV-positive women identified through PMTCT services, as well
as to their children, are included in OVC, Care and Support, and other sections of the COP09.
Technical Assistance and Training
SCMS will continue to improve the quality, accuracy, and frequency of PMTCT commodities forecasting and
supply planning in partnership with the GF, Clinton Foundation, UNITAID, and other donors through support
to the PSP Cellule ARV. In FY09, the systems that track and manage ARVs will be expanded to include
these other commodities with the introduction of a Laboratory LMIS. SCMS will also ensure that a rational
distribution plan is pre-calculated for each partner, based on prior consumption and validated at least
quarterly using client data and physical inventory spot-checks.
Wraparound Programs
SCMS will continue to support more rational, coordinated planning of inputs from other donors, including
EU, GF, and Clinton Foundation. The USG team is working with USAID/West Africa and OGAC to broker
technical assistance to the Global Fund TB program to develop its required Procurement Supply
Management (PSM) Plan to avoid blockage of disbursements from Geneva.
The PEPFAR/Cote d'Ivoire team has closely collaborated with other programs, notably the Global Fund
HIV, TB, and Malaria programs, to map the specific non-ARV support available for HIV-infected and -
affected people. For example, the malaria program distributes a number of insecticide-treated bed nets,
which can be targeted to pregnant women, young children, and PLWHA.
Systems-strengthening costs are included under the Strategic Information, ARV Drugs, Health Systems
Strengthening, and Lab Infrastructure sections of the COP09. This will cover all SCMS staff, consultants,
operations and overhead, and technical assistance and training.
New/Continuing Activity: Continuing Activity
Continuing Activity: 15149
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
15149 11155.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $300,000
International Supply Chain Management
Development Management System
11155 11155.07 U.S. Agency for Partnership for 5414 5414.07 Supply Chain $200,000
Emphasis Areas
Health-related Wraparound Programs
* Child Survival Activities
* Safe Motherhood
Human Capacity Development
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.01:
Because the PSP has a 1.5-year supply of syringes in stock from JSI, the Partnership for Supply Chain
Management Systems (SCMS) will procure only safety boxes in FY09. Although funds for commodities
procurement will be provided directly to SCMS, the MOH will be heavily involved in determining supply
volume and needs in the field. Collaboration with the PSP will ensure district-level procurements, help in
tracking stocks and responding to demands from local hospitals and health centers for safe-injection
supplies, and help manage the large stock of syringes. The program will ensure that a rational distribution
plan is pre-calculated for each site, based on prior consumption and validated at least quarterly using client
data and physical inventory spot-checks.
SCMS will continue to improve the quality, accuracy, and frequency of injection safety commodities
forecasting and supply planning in partnership other donor organizations, MMIS and other key partners
through support to the PSP Cellule ARV. Following directives from the Ministry of Health, all incoming
commodities will be delivered to the PSP who will ensure delivery and monitoring and evaluation of these
commodities to each service site. In FY09, the systems that track and manage ARVs will be expanded to
include these other commodities with the introduction of a Laboratory LMIS. SCMS will also ensure that a
rational distribution plan is pre-calculated for each partner, based on prior consumption and validated at
least quarterly using client data and physical inventory spot-checks.
Activity Narrative: Wraparound Programs
SCMS has and will continue to support more rational, coordinated planning of inputs from other donors,
including EU, GF, and Clinton Foundation. The USG team is working with USAID/West Africa and OGAC to
broker technical assistance to the Global Fund TB program to develop its required Procurement Supply
affected people. The malaria program distributes a number of insecticide-treated bed nets, which can be
targeted to pregnant women, young children, and PLWHA, for example. In its role as the primary source of
technical expertise for commodities forecasting and supply chain management,
New/Continuing Activity: New Activity
Continuing Activity:
* Family Planning
* Malaria (PMI)
* TB
Table 3.3.05:
• The COP08 activity was split into two programmatic areas (adult and pediatric)
Adult Care and Support
Since May 2005, PEPFAR Cote d'Ivoire has rapidly scaled up HIV/AIDS care and treatment across the
country. SCMS has procured OI drugs and HIV-related commodities to support the expansion of care
programs from 7,228 patients to more than 66,701 patients (in March 2008). In FY08, the SCMS project
procured and delivered cotrimoxazole for 126,000 patients as well as 90,000 bed nets and 16,000 water
purification kits for a targeted 36,000 persons. As the Cote d'Ivoire program expands, SCMS has played a
key role in providing technical assistance to coordinate accurate and frequent commodities forecasts and
improve real-time stock management activities at facility, district, and central levels of the health system.
SCMS will procure and deliver a standard package of palliative care materials to the PSP central
warehouse and ensure pre-arranged distribution planning for all incoming orders to facilitate in-country
management. The program will ensure that a rational distribution plan is pre-calculated for each site, based
on prior consumption and validated at least quarterly using client data and physical inventory spot-checks.
With FY09 funding, SCMS will procure cotrimoxazole for 150,000 adults, enough to cover all identified
Activity Narrative: PLWHA (both ART patients and non-ART patients, estimated to total 174,800 by September 2009) who
should receive cotrimoxazole prophylaxis according to pre-established guidelines. In addition, SCMS will
procure insecticide-treated bed nets for 90,000 patients, clean-water kits (container and chemical products)
for 9,500 patient families for targeted distribution to those at highest risk (pregnant women and areas with
poor water quality), as well as other drugs for 140,000 patients (STI drugs, antifungal medicines, etc.).
SCMS will continue to improve the quality, accuracy, and frequency of palliative care commodities
forecasting and supply planning in partnership with the GF, Clinton Foundation, UNITAID and other donors
Continuing Activity: 16781
16781 10189.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $2,493,750
10189 10189.07 U.S. Agency for Partnership for 5414 5414.07 Supply Chain $1,100,000
Table 3.3.08:
Pediatric Care and Support
country. SCMS has procured OI drugs and HIV-related commodities to support the expansion of palliative
care programs from 7,228 patients to more than 66,701 patients (in March 2008). In FY08, the SCMS
project procured and delivered cotrimoxazole for 126,000 patients as well as 90,000 bed nets and 16,000
water purification kits for a targeted 36,000 persons. These figures include both adult and pediatric care and
treatment programs, with FY08 funds supporting a targeted 10,080 children.
As the Cote d'Ivoire program expands, SCMS has played a key role in providing technical assistance to
coordinate accurate and frequent commodities forecasts and improve real-time stock management activities
at facility, district and central levels of the health system.
The PEPFAR/Cote d'Ivoire team collaborates closely with other programs, notably the Global Fund HIV, TB,
and Malaria programs, to map the specific non-ARV support available for HIV-infected and -affected people.
The malaria program plans to distribute a number of insecticide-treated bed nets, which can be targeted to
pregnant women, young children, and PLWHA, for example. In its role as the primary source of technical
expertise for commodities forecasting and supply chain management, SCMS has and will continue to
support more rational, coordinated planning of inputs from other donors, including EU, GF, and Clinton
Foundation. The USG team is working with USAID/West Africa and OGAC to broker technical assistance to
the Global Fund TB program to develop its required Procurement Supply Management (PSM) Plan to avoid
blockage of disbursements from Geneva.
Activity Narrative: FY09 Activities
warehouse and ensure prearranged distribution planning for all incoming orders to facilitate in-country
With FY09 funding, SCMS will procure cotrimoxazole for 15,200 children (in syrup form for infants), covering
all identified pediatric patients (both ART patients and non-ART patients) who should receive cotrimoxazole
prophylaxis according to pre-established guidelines (for children according to WHO guidelines). In addition,
SCMS will procure other basic medications used in the care of pediatric HIV patients.
Table 3.3.10:
OVC
country. Care and support for orphans and vulnerable children (OVC) has grown from 2,199 OVC in 2005 to
38,747 as of March 2008. As the Cote d'Ivoire program expands, SCMS has played a key role in providing
technical assistance to coordinate accurate and frequent commodities forecasts and improve real-time
stock management activities at facility, district and central levels of the health system.
To date SCMS, as part of an integrated care and support program for OVC, has procured and delivered a
basic package of support materials including bed nets, water purification tablets, paracetamol, albendazole,
malaria treatment, oral rehydration solution, and ammoxicillin for a targeted 63,000 OVC in FY08 SCMS
technical assistance enhanced the institutional capacity of the PSP, health districts, and targeted service
facilities to ensure adequate management of HIV/AIDS products and other health commodities. SCMS also
strengthened the PSP commodities management unit to better forecast and manage commodities for all
service sites in the National HIV/AIDS Care and Treatment Program.
With FY09 funds, SCMS will continue strong technical and management assistance to support the PSP in
its leadership and coordination role in the national HIV/AIDS program. In the program area of OVC, SCMS
will continue to procure and deliver a standard package of commodities to support orphans and vulnerable
children through the community activities of other PEPFAR implementing partners. These kits will include
Activity Narrative: bed nets, water purification tablets, paracetemol, albendazole, malaria treatment, oral rehydration solution,
and ammoxicillin. Specific needs projections will be negotiated with the MOH, the National OVC Program
(PNOEV) of the Ministry of the Family, Women, and Social Affairs, and other partners in support of the
overall PEPFAR FY09 target of 70,000 OVC.
Technical Assistance
SCMS will continue to improve the quality, accuracy, and frequency of OVC commodities forecasting and
supply planning in partnership with the GF, Clinton Foundation, UNITAID and other donors through support
to the PSP Cellule ARV. Following directives from the Ministry of Health, all incoming commodities will be
delivered to the PSP who will ensure delivery and monitoring and evaluation of these commodities to each
service site. In FY09, the systems that track and manage ARVs will be expanded to include these other
commodities with the introduction of a Laboratory LMIS. SCMS will also ensure that a rational distribution
plan is pre-calculated for each partner, based on prior consumption and validated at least quarterly using
client data and physical inventory spot-checks.
Continuing Activity: 17125
17125 17125.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $506,200
Table 3.3.13:
COP09 Activities
SCMS will procure and deliver rapid test kits and consumables for 400,000 people being tested for HIV by
CT programs to the PSP central warehouse and ensure prearranged distribution planning for all incoming
orders to facilitate in-country management. The program will ensure that a rational distribution plan is pre-
calculated for each site, based on prior consumption and validated at least quarterly using client data and
physical inventory spot-checks.
SCMS will continue to improve the quality, accuracy, and frequency of VCT commodities forecasting and
supply planning in partnership other donor organizations and key partners EGPAF, ACONDA, and ICAP
commodities to each service site. In COP09, the same systems that track and manage ARVs will be
expanded to include these other commodities with the introduction of a Laboratory LMIS. SCMS will also
ensure that a rational distribution plan is pre-calculated for each partner, based on prior consumption and
validated at least quarterly using client data and physical inventory spot-checks.
Activity Narrative: broker technical assistance to the Global Fund TB program to develop its required Procurement Supply
Table 3.3.14:
During the past three years, SCMS has provided TA to strengthen the institutional capacity of the Public
Health Pharmacy (PSP) and of at least 68 selected health districts and HIV/AIDS care and treatment sites
to improve the management of drugs and commodities. SCMS has provided ongoing technical and
management support to HIV/AIDS supply-chain coordination at the central and district levels.
In addition to procuring most HIV/AIDS-related drugs and consumables for PEPFAR CI, SCMS will use
FY09 funds to continue technical and management assistance in support of the PSP. SCMS will be held
accountable for specific performance results and will adjust its operational plan, in consultation with the
USG team, the National HIV/AIDS Care and Treatment Program (PNPEC), and the PSP, as needs evolve.
SCMS will regularly update national HIV/AIDS commodities forecasts and validate calculations based on
use patterns and will provide ongoing analysis of commodities consumption compared to patient treatment
data. SCMS will also advise the MOH and partners on current pharmaceutical market developments, USG-
disseminate a sustainable decentralization plan. SCMS will strengthen the LMIS by providing TA to assess
and enhance existing systems and/or develop new tools to better inform traceability of ARVs and other
commodities.
ARV Drugs
SCMS has played an integral role at all levels of the ARV supply chain from commodities forecasting and
procurement to warehousing, distribution, and commodities tracking. PEPFAR designated SCMS to be the
procurement agent for commodities and as such, has been responsible for coordinating national ARV drug
forecasts, quantifications, supply plans, procurements and deliveries. To date, SCMS, in collaboration with
other PEPFAR implementing partners, has performed four national quantifications and has provided
quarterly revisions to the supply plan for partner review and procurement planning purposes.
Through technical assistance to the PSP, PNPEC, MOH, PEPFAR implementing partner organizations and
other key partners, SCMS has played an integral role in improving all aspects of the national ARV and
HIV/AIDS commodity supply chain. In FY07-08, SCMS developed paper-based ARV logistics management
tools and worked with the MOH to disseminate the tools nationwide. In the past three years SCMS has built
capacity by training 22 trainers at the central level and 419 service providers at district and treatment sites
on HIV/AIDS commodities management and introduced ARV dispensing tools (ADT) at all treatment sites.
In coordination with PNPEC, SCMS has monitored this system and performed a mid-term evaluation of the
tools in FY08. Additionally, SCMS procured computers and initiated the implementation of the SIMPLE-1
ARV dispensing software in at least 42 health centers and SIMPLE-2 software in at least 68 districts.
In FY08, SCMS addressed warehousing and distribution needs by installing the WMS MACS solution at the
PSP's central warehouse. MACS further enhances the PSP's inventory management and distribution
systems and has enhanced the transparency of HIV/AIDS commodities management to decrease stock-
outs, overstocks, and emergency orders.
SCMS completed the physical upgrades to the PSP warehouse and prepared comprehensive SOPs for all
ARV-related PSP tasks. The program prepared, coordinated, and managed on-the-job warehouse staff
training for basic operations of receiving, picking, checking, packing, and dispatch as well as supervision,
security, and safety.
Commodities Forecasting
In FY09, SCMS will participate in the Coordinated Procurement Planning (CPP) for HIV/AIDS aimed at
strengthening supplies through donor coordination. As part of this effort, SCMS will build on existing
systems and mechanisms and work under country leadership.
SCMS will continue to improve the quality, accuracy, and frequency of ARV commodities forecasting and
to the PSP Cellule ARV. Using the June 2008 revised Stags, SCMS will perform a 24-month ARV
quantification and one-year supply plan. The forecast will include PMTCT patients as well as ARV needs for
post-exposure prophylaxis (PEP).
Activity Narrative: SCMS will continue collaboration with PSP staff, CDC/Retro-CI, PNPEC, the Laboratoire National de la
Sante Publique (LNSP), Clinton Foundation, GF, other donor organizations, and PEPFAR implementing
partners (EGPAF, ACONDA, ICAP, and a new treatment partner) to make quarterly revisions to the national
supply plan as well as to conduct regular cross-over analyses to compare commodities dispensed by the
PSP and specific sites with the actual patient data to inform clinical-services decisions. In addition, SCMS
will have monthly technical coordination committee meetings with the above partners to discuss the current
inventory of ARVs and other HIV/AIDS commodities. In an effort to strengthen capacity at the regional and
district pharmacy level, SCMS will train pharmacists in forecasting and supply planning for ARV and
monitoring and evaluation methodologies.
SCMS will procure first- and second-line ARVs based on a nationally approved supply plan. The Cote
d'Ivoire government has agreed to fund third-line ARVs during the FY09 program year. In FY09, the
PEPFAR program expects to be providing ART for 39,000 patients with a target of 60,000 patients by
September 2009. SCMS will procure drugs for 10 full months for this cohort and will include drugs for
21,000 new ART patients, with a five-month buffer supply, which combined with remaining supplies should
support the PEPFAR ART program through July 2010. Implementing partners plan to provide PMTCT
services (ARV prophylaxis) to 9,600 women by September 2009.
Cote d'Ivoire's Round 8 application was not successful. After the Round 2 HIV project ends in March 2009,
it is expected that the GF will continue to provide ARVs and lab commodities to support its current patients.
The USG team is represented on the CCM and in regular consultation with the GF principal recipient, and is
prepared to help address potential programmatic implications of a GF service-delivery gap as well as to join
MSH in providing technical assistance for an expected GF Round 9 application.
With FY09 funds, SCMS intends to continue several technical assistance activities that, in combination, are
expected to greatly enhance transparency of commodities management and decrease stock-outs and
emergency orders due to inadequate forecasting at all levels. In addition to the activity areas listed below,
SCMS staff will:
• Receive further training on proper procurement procedures for both international and local acquisitions;
• Work in collaboration with the MOH and other partners to maintain a web-based ordering system. Client
Resource Manager (CRM), will also authorized partners to log-in and review orders from SCMS, track their
delivery progress, and confirm historical data regarding their orders;
• Maintain an inventory tracking system for EP-procured HIV commodities. The WMS MACS and its
integration with LMIS software will further enhance the PSP's inventory management and distribution
system;
• Complete the implementation of SIMPLE-1 and SIMPLE-2 at all facility-level and district pharmacies to
track ARV dispensing data used in stock management and forecasting efforts;
• Continue to improve the quality, accuracy, and frequency of ARV commodities forecasting and supply
planning in partnership with the GF, Clinton Foundation, UNITAID and other donors through support to the
PSP Cellule ARV. Following directives from the Ministry of Health, all incoming commodities will be
service site;
• Ensure that a rational distribution plan is pre-calculated for each partner, based on prior consumption and
LMIS
Following changes to the national regimens, the ARV logistics management toolkit which was developed
and nationally disseminated in FY07-08 and accompanying training of trainers manuals will be revised,
reproduced and disseminated with FY09 funding. The SCMS tools development will strengthen the
transparency and national ownership of supply-chain responsibilities and enable the PSP to access monthly
inventory and dispensing reports from each treatment site. These reports and analyses will signal to care
and treatment stakeholders anytime the projected virtual stock of any ARV or HIV related commodity will be
less than three months at the national level or at any site.
In COP09, the site-level monthly report submission will be followed up with SCMS supported supervision
visits to both the intermediary (including other sites reporting to the PSP) and site level treatment facilities to
reinforce training and to monitor reporting accuracy. SCMS will ensure computerized proactive supply-chain
management systems, specifically procurement, inventory management and distribution systems include
detailed information on ARVs and OI drugs.
Following the MACS installation at the central level in FY08, SCMS will build upon the MACS solution in
FY09 by installing MACS-LMIS software at both the central and district level. When the programs are
interfaced, ARV and Laboratory logistics data collected at the site level will give both the district and central
level pharmacies actual consumption data. Adding the WMS solution at the district level provides districts
with the same stock management tools available at the central level. Following the implementation of the
WMS-LMIS solution, pharmacists from each district will be trained in the software.
SCMS will scale up the PDA LMIS data collection system developed in FY08 to support the PSP ARV and
OI drug data collection effort. Following the completion of the pilot program in five sites in FY08, the PDA
program will be scaled up to include all district level facilities.
Warehousing and Distribution
Following the assessment of the district pharmacies in FY08, SCMS will complete an evaluation of the
physical infrastructures of the district pharmacies and make recommendations on their storage needs.
SCMS will create an implementation plan for meeting warehousing standard guidelines and will strengthen
storage conditions for the 5 district pharmacies. In this regard, SCMS will build capacity within the district
pharmacy infrastructures through the purchase of equipment, training, and supervision.
Activity Narrative: SCMS will continue to reinforce the storage and distribution capacity of the central level PSP warehouse. In
addition, SCMS will provide technical assistance to reinforce the PSP's capacity to assess, make
recommendations, and renovate their district warehouse at regional headquarters so that it is in compliance
with recognized standard storage conditions for ARVs, OI drugs, and other HIV/AIDS commodities. In FY09,
SCMS will also analyze and reinforce the PSP's distribution system by making system and equipment
recommendations
Capacity Building
SCMS will continue to provide technical assistance to further build capacity within the PSP, PNPEC, and
MOH. SCMS will continue to provide technical assistance to further build capacity within the PSP, PNPEC,
and MOH. At the PSP, SCMS will deploy a site quality-assurance manager as required to oversee upgrades
to physical infrastructure and management systems. The program will prepare, coordinate, and manage on-
the-job warehouse staff training for basic operations of receiving, picking, checking, packing, and dispatch
as well as supervision, security, and safety and security of PEPFAR commodities.
SCMS will train the DPM and PSP staff on importation processes and will also provide technical assistance
to the DPM on the purchase and training on an incinerator. SCMS plans technical assistance activities to
advise PNPEC on best practices and tools for the dissemination of up-to-date information on regimen and
testing protocols.
Continuing Activity: 15150
15150 4572.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $26,864,486
10187 4572.07 U.S. Agency for Partnership for 5414 5414.07 Supply Chain $17,475,000
4572 4572.06 U.S. Agency for Partnership for 3382 92.06 Working $2,440,000
International Supply Chain Commodities
Development Management Fund
Construction/Renovation
Estimated amount of funding that is planned for Human Capacity Development $250,000
Program Budget Code: 16 - HLAB Laboratory Infrastructure
Total Planned Funding for Program Budget Code: $10,028,000
Total Planned Funding for Program Budget Code: $0
Program Area Narrative:
The national public health laboratory system in Cote d'Ivoire has three levels: the tertiary or reference level with laboratories at the
four university teaching hospitals, five specialized institutes including the National Public Health Reference Laboratory (LNSP) and
National Blood Bank (CNTS), and research centers; the secondary or intermediate level with 18 regional hospital and 56 general
hospital laboratories; and 1,486 primary health centers with basic laboratory services. Private laboratories (195) also provide a
range of laboratory services. Of the 1,560 health structures authorized to provide laboratory services, fewer than 300 are
operational, and few of these provide the full range of laboratory services.
The LNSP is the National Public Health Reference Laboratory with the mission to develop and implement laboratory standards, to
organize, implement and monitor Quality Assurance (QA)/Quality Control (QC) procedures, and regulate laboratory creation and
operation. The weak human resource capacity and lack of clear policies on the role of this institution—in addition to a poorly
resourced infrastructure—have been a limiting factor in its ability to perform its mandate. Cote d'Ivoire has three other laboratories
functioning as reference laboratories to support the HIV/AIDS program. The Institut Pasteur Cote d'Ivoire (IPCI) is the national
reference laboratory for TB diagnosis and surveillance of infectious/epidemic diseases. CeDres, a central lab affiliated with the
university teaching hospital in Treichville, acts as the reference laboratory for immunology and has technical and human capacity
to work closely with IPCI in supporting the TB lab program. CIRBA is a private laboratory in Abidjan that serves a large HIV
outpatient clinic and has technical and human resource capacity for molecular diagnosis.
The national school of health professional (INFAS) has the mission to train laboratory technicians, nurses, midwives, etc. in a
three-year post-secondary school program. From 1991 to 2000, only 216 lab technicians and 21 lab engineers were trained.
Among the principal limitations of the school are inadequate infrastructure and equipment, a lack of teachers, and incomplete
HIV/AIDS training modules. A human resource evaluation conducted in 2005 by Aby Associates showed there was a need for 533
additional laboratory technicians to support the public health system in reaching the HIV/AIDS national strategic plan goals by
2008. INFAS is part of the Ministry of Health department of training and research (DFR) in charge of coordinating, evaluating and
monitoring pre- and in-service training of health professionals. The MOH also has a department charged with developing and
maintaining health infrastructure and equipment (DIEM); DIEM has decentralized services (CRIEM) in the 18 regions of Cote
d'Ivoire and has the mandate to oversee all procurement, building, and renovation of health infrastructures and equipment.
In 2004, Cote d'Ivoire defined a minimum laboratory services package within the tiered public health laboratory system, but it is
not systematically implemented. While HIV serology testing services are implemented at all levels of the health pyramid, HIV
clinical laboratory monitoring (CD4 testing, full blood count, clinical chemistry) of persons receiving antiretroviral therapy is
primarily supported at the tertiary and secondary levels. Diagnosis of OIs, TB, and malaria are not provided at all levels of the
health pyramid. HIV molecular diagnosis is performed only at several central laboratories.
No overarching strategic plan exists at the national level for the integration of HIV/AIDS, TB, malaria, and opportunistic infection
diagnosis and treatment services despite the fact that each of the MOH departments involved in laboratory activities has
developed its own strategic plan. The development of such a global plan is important for better coordination and use of available
funds and opportunities to strengthen the entire laboratory system.
FY08 response
The government of Cote d'Ivoire (GOCI) made a commitment to the rapid expansion of CT services and outlined in its 2006-2010
national strategic plan the intention to open 460 CT sites by the end of 2010. By the end of 2007, with PEPFAR support, 300 (188
CT, 112 PMTCT) sites were operational. Despite progress, national coverage of HIV testing services remains weak in some
areas, particularly in rural settings.
The MOH created a new national laboratory permanent commission to address all gaps within the laboratory network, to develop
laboratory policies and quality assurance/control standards, and to regulate laboratory activities countrywide. Under the leadership
of this commission, five national policies have been developed related to the organization of a national quality assurance program,
the organization of laboratories in the health system, and the implementation of a minimum biological package; these policies
have been approved by the MOH
In 2007, major lab activities were directly supported by Retro-CI in collaboration with PNPEC and other key national stakeholders.
A new HIV whole-blood finger-prick-based testing algorithm combining Determine, Bioline (confirmatory), and Stat-Pak (as a tie-
breaker) have been evaluated, validated by the MOH, and piloted at 70 sites. An HIV laboratory logbook was developed in
collaboration with CDC-Atlanta, validated by the MOH, and piloted at the same 70 sites. Both the new HIV testing algorithm and
the new logbook are in the process of general implementation across the country.
In FY07, PEPFAR provided technical assistance to monitor and maintain the quality of HIV testing services provided at PEPFAR-
supported sites through retesting of specimens from 188 CT sites to evaluate the competency of those health professionals and
allied health professionals implementing the testing; periodic onsite visits were conducted to assess the overall QA program. In
addition to the existing quality control activity, in 2008 Retro-CI in collaboration with LNSP and PNPEC started a national external
quality assurance program for HIV serology using proficiency testing panels. A total of 128 lab personnel, including 25 regional
quality assurance managers and the national pool of trainers, were trained. A total of 98 sites (65 CT-PMTCT sites, 33 hospital
labs) participated in the first phase of this EQA program.
Currently, only CDC/Retro-CI is performing DNA-PCR for early infant diagnosis (EID). A 6 month pilot phase was conducted in
2007/2008 on 25 PMTCT sites with a total of 1,330 PCR assays performed and 100 health providers trained for the collection of
DBS. For the roll-out PEPFAR is currently renovating and equipping three additional central labs (CIRBA, CeDres and IPCI) to
support the expansion of the program. To date, 33 PMTCT sites offer EID services with a total of 2,807 PCR tests performed.
Retro-CI has also performed 1,192 viral load, 9,747 hematology, 34,756 chemistry, 9,747 CD4 count assays, and 9,573 HIV
serology tests for PEPFAR-supported sites.
The American Society for Microbiology (ASM) and Retro-CI have worked closely with the national TB program (PNLT) and the TB
reference laboratory (IPCI), CeDres, and CAT Adjame (the largest urban TB treatment center) to: (1) customize and train 12 lab
technicians on the new smear microscopy training package developed by CDC and WHO; (2) improve diagnostic capacity through
laboratory renovation, procurement of equipment (based on a standardized, harmonized list), and training; (3) support the
continued development of national TB diagnostic capacity (TB diagnostic equipment is being procured through ASM and a new
collaboration with FIND); (4) TA to the PNLT and IPCI related to laboratory renovations to ensure that both institutions meet
international criteria for a P3 laboratory; (5) provide technical assistance to IPCI to assess and strengthen the existing EQA
program for smear microscopy, with the introduction of blind rechecking of the smear microscopy through a pilot at 35 TB testing
centers.
In January 2008, the PEPFAR lab team, in collaboration with national stakeholders, developed a standardized list of lab
equipment for PEPFAR-supported sites that reduced the number of choices of instruments for each type of laboratory test based
on national criteria. In 2008, Retro-CI worked closely with SCMS and PNPEC to develop a laboratory information logistic system
allowing collection of monthly lab test consumption and monitoring of stocks both at peripheral and central levels.
In-service training sessions on HIV testing, CD4 count, hematology, chemistry, and direct-smear microscopy have been
coordinated and conducted respectively by the PNPEC and PNLT using standardized training modules. However, these trainings
were not well coordinated.
Retro-CI with PNPEC, LNSP, and IPCI initiated supervision of 14 district and regional laboratories offering HIV laboratory
services. In addition, Retro-CI has conducted 45 supervision missions related to HIV rapid testing activities at 16 CT, 12 PMTCT,
and 23 CT/PMTCT sites.
FY09 Priorities
In FY09, PEPFAR, through Retro-CI, the CDC Lab Coalition partners (APHL, ASM, ASCP, CLSI), LNSP, IPCI, INFAS, and
CeDres, will support the development of HIV diagnosis and biological monitoring, surveillance, and management of EQA
programs. ASM and CLSI will provide technical assistance to the national laboratory network to develop quality laboratory
systems and will assist national laboratories in complying with international standards and develop an accreditation plan; APHL
and Retro-CI will assist the MOH in developing a national laboratory strategic plan; and ASCP will support INFAS to improve
overall training activities.
FY09 lab priorities include:
1. The development of a national strategic laboratory plan to serve as the basis for all national laboratory activities and
coordination of national programs, stakeholders, and donor agencies in improving the national laboratory network.
2. Capacity building to strengthen the laboratory system throughout the country.
To strengthen the lab program and ensure better coordination and leadership of national laboratory institutions, PEPFAR will
support the MOH through its CDC cooperative agreement for the following activities:
PEPFAR will support LNSP to assume leadership as a true national reference laboratory by enhancing its infrastructure and
human resource capacities, providing technical assistance to improve competencies for HIV diagnosis and expertise for the
establishment and management of a national external quality assurance program. LNSP will assume more responsibility
(incrementally) for most of the reference HIV testing and ANC sero-surveillance and the evaluation of new HIV test kits,
algorithms, and alternative blood collection methods
ASM will assist IPCI for the implementation of diagnostic capacity related to TB, OIs, and STIs and a national EQA program at six
STI clinic laboratories and six regional laboratories.
PEPFAR will support INFAS for the development of national laboratory human resources. INFAS infrastructure will be enhanced
to increase its educational capacities; this will include the procurement of laboratory equipment and renovation of laboratory
classrooms. ASCP will assist INFAS to develop and improve training curricula for pre- service trainings of lab technicians and
organize training for trainers and teachers.
PEPFAR will support the PNPEC and DFR for the organization, coordination, evaluation, and monitoring of in-service trainings for
laboratory technicians. A national in-service training plan will be developed that will include training needs from other PEPFAR
HIV/TB and malaria partners.
PEPFAR will support the DIEM to develop and implement a national program for the maintenance of lab equipment in public
health facilities.
3. Support for rapid scale-up of HIV/AIDS laboratory services:
In FY09, PEPFAR will focus its support on improving the quality of laboratory services countrywide. PEPFAR will support (1)
strengthening laboratory infrastructure, (2) scaling up the implementation of the QA program for all laboratory testing, and (3)
improving in-service training and implementing a specimen referral system countrywide, through its implementing partners
(EGPAF, ACONDA, ICAP, etc.). Scale-up will be achieved by increasing CT and PMTCT services, clinical laboratory monitoring,
and rapid roll-out of early infant HIV diagnosis through changes in policies and innovative strategies. Implementing partners plan
to continue to support biological monitoring at 700 sites with the opening of an additional 250 CT sites and 136 PMTCT sites and
with testing of up to 10,000 specimens for HIV early infant diagnosis with transfer of DBS-based DNA-PCR technology to three
national central laboratories.
4. CLSI will assist Retro-CI, LNSP, and IPCI in complying with international standards and development of an accreditation plan.
5. Procurement of laboratory commodities and establishment of a laboratory information logistic system: In FY08, new national
HIV treatment guidelines were adopted by the MOH that include five additional biological parameters. PEPFAR will continue to
support SCMS for the quantification and the procurement of laboratory commodities to support the national HIV/AIDS program.
6. PEPFAR will fund Retro-CI to continue to support the national HIV/AIDS program through provision of routine HIV testing at the
University Hospital in Treichville and will serve as a back-up laboratory for PEPFAR CT and care and treatment partners for
approximately 10,000 patients. Retro-CI will continue to coordinate PEPFAR-supported laboratory activities in collaboration with
PNPEC and relevant national laboratory institutions and transfer expertise by providing technical assistance to the laboratory
network through training, supervision of laboratory activities, and implementation of quality assurance programs under the
leadership of LNSP. Retro-CI will work closely with the national association of laboratory technicians to support continuing
education related to best laboratory practices by supporting two annual meetings for this purpose.
All USG-funded partners will report to the PEPFAR strategic information team with quarterly program results and other requested
program data. To help build one national monitoring and evaluation system, all USG-funded partners will participate in quarterly SI
meetings and will implement activities based on decisions made during those meetings.
Note: Requested FY09 funding for Laboratory Infrastructure will be supplemented by FY08 carryover funds to support INFAS
rehabilitation and some scale-up costs.
Table 3.3.16:
Lab Infrastructure
SCMS has been the designated procurement agent for PEPFAR commodities and as such, has been
responsible for coordinating national ARV drug quantifications, supply plans, procurements and deliveries.
In FY08 SCMS performed well in rapid procurement of ARV drugs, laboratory reagents, rapid test kits, and
OI drugs, but laboratory consumables and equipment continued to suffer delays during the procurement
process.
other key partners, SCMS has played an integral role in improving all aspects of the national HIV/AIDS
commodity supply chain. SCMS, in collaboration with other PEPFAR implementing partners ACONDA,
EGPAF and ICAP, has performed two national laboratory quantifications. Since November 2007, SCMS has
provided quarterly revisions to the supply plan for partner review and procurement planning purposes.
Ongoing TA, including laboratory commodities identification training, has strengthened the PSP's ability to
forecast and manage commodities and thus avoid supply problems.
In FY08, SCMS addressed warehousing and distribution needs by installing the WMS, MACS, solution at
the PSP's central warehouse. MACS facilitates the PSP's inventory management and distribution systems
and has greatly enhanced the transparency of commodities management and decreased stock-outs and
emergency orders. In addition, SCMS performed an assessment of the PSP's satellite warehouse and
developed a rehabilitation plan.
During FY08, SCMS initiated a national laboratory assessment and developed laboratory system design
aimed to improve the national ARV and HIV/AIDS commodity laboratory infrastructure. The system design
Activity Narrative: will ensure that the national laboratory system will improve facility functionality and make recommendations
on best practices to minimize stock related issues.
SCMS will continue to procure and deliver reagents and consumables to support ART and non-ART
patients to laboratory monitoring sites. SCMS will continue to improve laboratory infrastructure and
equipment maintenance while reinforcing capacity by providing necessary training and supervision visits. As
follow-up to the laboratory assessment performed in FY08, SCMS will propose a list of essential laboratory
equipment for 34 sites.
Specific needs projections will be negotiated with the MOH, Global Fund, and other partners in support of
PEPFAR FY09 service-delivery targets. Based on current projections, SCMS will procure lab reagents and
consumables for monitoring of 60,000 ART patients (at $92 per patient for initial screening and $92 per year
for existing patients); laboratory reagents and consumables to train and retrain 600 lab technicians (at an
estimated cost of $108 per lab technician trained); and laboratory reagents and consumables to monitor
69,000 palliative-care patients (at $61 per patient), based on estimates of how many patients will be
monitored as recommended.
With FY09 funding, SCMS intends to continue several technical assistance activities that, in combination,
are expected to greatly enhance transparency of commodities management and decrease stock-outs and
delivery progress, and confirm historical data regarding their orders.
• Maintain an inventory tracking system for EP-procured laboratory commodities. The WMS, MACS, and its
system.
• Continue to improve the quality, accuracy, and frequency of HIV/AIDS laboratory commodities forecasting
and supply planning in partnership with the GF, Clinton Foundation, UNITAID and other donors through
support to the PSP Cellule ARV. Following directives from the Ministry of Health, all incoming commodities
will be delivered to the PSP who will ensure delivery and monitoring and evaluation of these commodities to
each service site.
SCMS designed and disseminated an ARV tracking tool (LMIS) nationwide and has designed a laboratory
commodities tracking tool that will be disseminated during the FY09 program year. The SCMS tools
development will strengthen the transparency and national ownership of supply-chain responsibilities and
enable the PSP to access monthly inventory and dispensing reports from each treatment site. These reports
and analyses will signal to care and treatment stakeholders anytime the projected virtual stock of any ARV
or HIV-related commodity will be less than three months at the national level or at any site.
Following the FY08 laboratory assessment, the resulting laboratory systems design will be implemented in
FY09. SCMS will collaborate with PSP, PNPEC, CDC/RETRO-CI, the Laboratoire National de la Sante
Publique (LNSP) as well as PEPFAR implementing partners to implement a laboratory LMIS; this will
include tools design, reproduction dissemination and program scale up. SCMS will coordinate the
development of a national laboratory commodities database.
With FY09 funds, the site-level monthly report submission will be followed up with SCMS supported
supervision visits to both the intermediary facilities (and others reporting to the PSP) on a quarterly basis as
well as to site level treatment facilities on a monthly basis. These supervisory visits, supported by SCMS in
collaboration with the EU, will reinforce the tools training and monitor reporting activity. The supervision
visits will be carried out by district level pharmacists and regional supervisors.
Following the MACS installation at the central level in FY08, SCMS will build upon the MACS solution by
installing MACS-LMIS software at both the central and district level. When the programs are interfaced,
ARV and Laboratory logistics data collected at the site level will give both the district and central level
pharmacies actual consumption data. Adding the WMS solution at the district level provides districts with
the same stock management tools available at the central level. Following the implementation of the WMS-
LMIS solution, pharmacists from each district will be trained in the software.
MOH. At the PSP, SCMS will deploy a site quality-assurance manager as required to oversee upgrades to
physical infrastructure and management systems. The program will prepare, coordinate, and manage on-
as well as supervision, security, and safety.
Following the installation of the MACS WMS, SCMS will assure PSP staff are trained in its effective use.
SCMS will also support upgrades to the PSP vehicle fleet and associated commodities handling equipment
to improve the efficiency of distribution systems and the safety and security of PEPFAR commodities.
SCMS will commence physical upgrades to high-volume storage facilities to ensure the safety and security
of PEPFAR commodities.
Activity Narrative: SCMS will train the DPM and PSP staff on importation processes and will also provide technical assistance
to the DPM on the purchase and training on an industrial incinerator. SCMS plans technical assistance
activities to advise PNPEC on best practices and tools for the dissemination of up-to-date information on
regimen and testing protocols.
Continuing Activity: 15151
15151 10191.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $6,672,050
10191 10191.07 U.S. Agency for Partnership for 5414 5414.07 Supply Chain $800,000
amounts of commodities with its own funds.
LMIS Activities
Paper-based ARV and Laboratory Commodities Tracking
With FY09 funding, SCMS will continue to develop paper-based LMIS tools, including the ARV tracking tool
that was nationally disseminated in FY07-08 as well as the laboratory commodities tracking tool that will be
disseminated during the FY09 program year. Following changes to the national regimens in June 2008, the
ARV logistics management toolkit and training-of-trainers document will be revised, reproduced and
disseminated in FY09.
The SCMS tools development will strengthen the transparency and national ownership of supply-chain
responsibilities and enable the PSP to access monthly inventory and dispensing reports from each
treatment site. These reports and analyses will signal to care and treatment stakeholders anytime the
projected virtual stock of any ARV or HIV-related commodity will be less than three months at the national
level or at any site.
PDA data collection tool
SCMS worked with Alliance Nationale Contre le SIDA to develop a PDA reporting system using GPS
technology. This program was scaled up in FY08 to include the Ministry for the Fight Against AIDS (MLS)
and will continue through FY09. The first phase of this program collected community based patient
information in seven regions with 21 NGOs. In FY09, the PDA program will be scaled up in to include all
Activity Narrative: regions
The second phase of the PDA program supports the PSP's ARV and OI drug data collection efforts.
Following a pilot in five districts, SCMS will be scaled-up to include all districts in FY09.
The site-level monthly report submission will be followed up with SCMS supported supervision visits to both
the intermediary facilities (and others reporting to the PSP) on a quarterly basis as well as to site level
treatment facilities on a monthly basis. These supervisory visits, supported by SCMS in collaboration with
the EU, will reinforce the tools training and monitor reporting activity. The supervision visits will be carried
out by district level pharmacists and regional supervisors. In COP 09 SCMS will be responsible for the
completion of the installation of SIMPLE 1 software at the facilities level.
SCMS will continue to refine and improve the quality, accuracy, and frequency of ARV and other
commodities forecasting and supply planning in partnership with the GF, Clinton Foundation, UNICEF and
others through support to the PSP Cellule ARV. The project will perform these updates in collaboration with
PSP staff, RETRO-CI, and the National Reference Laboratory. By doing so, SCMS continues to transfer
these skills to partner organizations and also reinforces regular cross-over analyses to compare
commodities dispensed by the PSP and specific sites with the actual patient data to inform clinical-services
decisions. With FY09 funding, SCMS will further support PSP and PNPEC to assure that the assumptions
used in the quantification are disseminated to the facility level through workshops in each of the 19 regions
in Cote d'Ivoire. SCMS will also train regional pharmacists in forecasting and supply planning for ARVs, OI
drugs, and laboratory commodities.
Commodities Tracking
SCMS will Work in collaboration with the MOH and other partners to maintain a web-based ordering
system. Client Resource Manager (CRM), will also authorized partners to log-in and review orders from
SCMS, track their delivery progress, and confirm historical data regarding their orders. The project will also
maintain an inventory tracking system for EP-procured HIV commodities. The WMS, MACS, and its
integration in FY09 with LMIS software will further enhance the PSP's inventory management and
distribution system.
Warehousing
The WMS, MACS, further enhances the PSP's inventory management and distribution systems. This
solution has greatly enhanced the transparency of commodities management and decreased stock-outs
and emergency orders. SCMS will continue to ensure computerized supply-chain management systems,
specifically procurement, inventory management and distribution systems include detailed information on
ARVs, OI drugs, laboratory reagents, and testing materials, as well as commodities for palliative care and
OVC support. Following the MACS installation at the central level in FY08, SCMS will build upon the MACS
solution by installing MACS-LMIS software at both the central and district level. When the programs are
interfaced, ARV and laboratory logistics data collected at the site level will give both the district and central
level pharmacies actual consumption data. In addition, the WMS solution at the district level will provide
districts with the same stock management tools as the central level. Following the implementation of the
Continuing Activity: 15152
15152 5846.08 U.S. Agency for Partnership for 7061 5414.08 Supply Chain $500,000
10192 5846.07 U.S. Agency for Partnership for 5414 5414.07 Supply Chain $110,000
5846 5846.06 U.S. Agency for Partnership for 3382 92.06 Working $110,700
Estimated amount of funding that is planned for Human Capacity Development $350,000
Table 3.3.17:
